INSIGHTS ON PHARMACEUTICAL PACKAGING

• Characterizing The E&L Profile Of Stoppers For Drug Stability

  The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.

• Meeting Annex 1: A Proactive Approach To Regulatory Compliance

  It was imperative for a large European CMO producing multiple biologics to select the right product quality and value for each customer to comply with the August 2023 EU GMP Annex 1 revision.

• 3D Screen Printing: Enabling A New Generation Of Complex Formulations

  Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.

• Providing Packing And Blinding Solutions For An Innovative Drug Start-Up

  Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.

• Collagen Based Products For Regenerative Medicine

  1/5/2026

  Sterile packaging is vital for collagen-based regenerative medicine products. Learn how advanced integrity testing methods help prevent contamination, ensuring safety and reliability.

• Commercializing Innovation

  3/13/2026

  Explore how packaging safeguards life science products and why innovation cultures matter. Oliver Stauffer offers grounded insights on turning scientific advances into sustainable, real-world impact.

• Bottling Solutions

  3/4/2025

  Explore a bottling solution that is meticulously engineered to adhere to the most stringent pharmaceutical standards, which guarantees that each product is crafted with unparalleled quality and precision.

• 5 Critical PUPSIT Considerations For Sponsors Targeting The EU Market

  1/22/2026

  To ensure compliance with EU GMP Annex 1 guidelines and drug product approval, familiarize yourself with PUPSIT: how it works, why it’s needed, and strategies to maximize success.

• Innovation For Subcutaneous Delivery Of Large-Volume Complex Biologics

  5/9/2024

  Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.